Yi‐Peng Fu

Microbiota in health and diseases

Targeting immunosuppressive adenosine in cancer

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Targeting adenosine for cancer immunotherapy

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

A robust gene expression signature for NASH in liver expression data

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments

Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection